ArticleMolecules (Basel, Switzerland)2025
Plasmon-Enhanced Piezo-Photocatalytic Degradation of Metronidazole Using Ag-Decorated ZnO Microtetrapods.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of advanced semiconductor-based catalysts for the rapid degradation of emerging pharmaceutical pollutants in water remains a critical challenge in environmental science. In this study, we present the synthesis, characterization, and catalytic performance of zinc oxide (ZnO) microtetrapods decorated with plasmonic Ag nanoparticles. These microtetrapods have been designed to enhance piezo-, photo-, and piezo-photocatalytic degradation of metronidazole (MNZ), a persistent antibiotic contaminant. ZnO microtetrapods were synthesized by high-temperature pyrolysis and using atmospheric-pressure microwave nitrogen plasma, followed by photochemical deposition of Ag nanoparticles at various precursor concentrations (0-1 mmol AgNO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.